Transplantation of human hepatic organoids rescues liver ischemic reperfusion injury in immune-deficient mice
Ontology highlight
ABSTRACT: The effectiveness and underlying mechanisms of organoid transplantation therapy in liver ischemia-reperfusion injury (IRI) remain underexplored. We aimed to investigate the therapeutic potential and biological processes of human adult stem cells (hASCs)-derived hepatic organoids (hHOs) in treating liver IRI in an immune-deficient murine model.
ORGANISM(S): Mus Musculus
SUBMITTER: Shusen Zheng
PROVIDER: PXD052240 | iProX | Mon May 13 00:00:00 BST 2024
REPOSITORIES: iProX
ACCESS DATA